Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference0.7%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.6%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1.0%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check81 days agoChange DetectedThe page has undergone significant content removal, including the deletion of the study's purpose, inclusion and exclusion criteria, and details about the treatment trial for genetic obesity. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference12%
Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.